FDA Panels to Advise on LABA Study Designs

Courtesy MedPage Today Allergy & Immunology  Tue, 03/09/2010 - 15:39

The FDA is seeking advice this week from two of its advisory committees on how manufacturers of a major group of asthma drugs should study their potential risks.


 

More related items

Beta-2 Receptor Variants Don't Affect LABA Response...
Against expectations, asthma patients with different genotypes for the beta-2 adrenergic receptor all responded well to long-acting beta agonist (LABA) asthma drugs, researchers said.

...
WASHINGTON (AP) -- FDA advisers recommend that drugs Serevent and Foradil no longer be used for asthma....

FDA Approves No-Comb Treatment for Head Lice
The FDA has approved Sklice, a no-comb, 10-minute treatment for head lice. The topical 0.5% ivermectin lotion can be used in kids as young as age 6 months.

Finger Pulse Oximeter Octive Tech 300C with Hard...
OctiveTech 300C Digital Finger Pulse Oximeter combines advanced technology with a stylish, wearable design. The outstanding interference resistance capacity against ambient light along with...

New 2009 Hi Bebe BT-200 Fetal Doppler/Heart Rate...
This is an FDA cleared fetal doppler with 2 -8.5 oz. of aquasonic ultrasound gel.


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com